๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

RFLPs for linkage analysis in families with glycogen storage disease type III

โœ Scribed by A. Mishori-Dery; N. Bashan; S. Moses; E. Hershkovitz; Y. Bao; Y. T. Chen; R. Parvari

Publisher
Springer
Year
1995
Tongue
English
Weight
426 KB
Volume
18
Category
Article
ISSN
0141-8955

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Difficult hGH treatment in a patient wit
Difficult hGH treatment in a patient with type III glycogen storage disease
โœ D. Larizza; G. Maggiore; D. Marzani; M. Maghnie; R. Ciceri ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer ๐ŸŒ English โš– 148 KB

The case of a boy affected by type III glycogen storage disease and total GH deficiency is reported. Substitutive treatment with hGH caused an extreme elevation of blood lipids. His lipid profile returned near to basal values 1 month after treatment was discontinued. The association of growth hormon

PRENATAL DIAGNOSIS IN A CHINESE FAMILY W
PRENATAL DIAGNOSIS IN A CHINESE FAMILY WITH TYPE Ia GLYCOGEN STORAGE DISEASE BY PCR-BASED GENETIC ANALYSIS
โœ WEN-JANE LEE; CHING-HWA YANG; ESTHER SHIH-CHU HO; AI SHIH; LIH-YUAN LIN; WEN-HAN ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 623 KB

Type Ia glycogen storage disease (GSD), an autosomal recessive metabolic disorder, is caused by a deficiency in glucose-6-phosphatase (G6Pase). We had previously identified the nature of the causative mutations in a Chinese family whose first two children were affected with type Ia GSD. Two differen

Phenotypical variability in glycogen sto
Phenotypical variability in glycogen storage disease type III with a recurrent AGL mutation c.750โ€“753delAGAC
โœ Minoru Okubo; Konstantinos Spengos; Panagiota Manta; Ekram Fateen ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 173 KB

Cranial nerve palsies (CNP) are a part of the clinical spectrum of chronic inflammatory demyelinating polyneuropathy (CIDP), but they are commonly associated with a more diffuse pattern. In a cohort of 146 CIDP patients, 2% presented isolated CNP and 17% had CNP associated with limb weakness or sens